Search Results - "Bolasco, P G"

Hemodiafiltration with endogenous reinfusion with and without acetate-free dialysis solutions: effect on ESA requirement by Bolasco, P G, Ghezzi, P M, Serra, A, Corazza, L, Murtas, S, Mascia, M, Cossu, M, Ferrara, R, Cogoni, G, Cadinu, F, Casu, D, Contu, B, Passaghe, M, Ghisu, T, Ganadu, M, Logias, F

“…Hemofiltrate reinfusion (HFR) is a form of hemodiafiltration (HDF) in which replacement fluid is constituted by ultrafiltrate from the patient 'regenerated'…”
Get more information

Corticosteroids in IgA nephropathy: a randomised controlled trial by Pozzi, Claudio, Bolasco, PierGiorgio, Fogazzi, GianBattista, Andrulli, Simeone, Altieri, Paolo, Ponticelli, Claudio, Locatelli, Francesco

“…IgA nephropathy is progressive in most cases and has no established therapy. In this randomised trial, we assessed the efficacy and safety of a 6-month course…”
Get full text

Effect of on-line hemodiafiltration with endogenous reinfusion (HFR) on the calcium-phosphorus metabolism: medium-term effects by Bolasco, P G, Ghezzi, P M, Ferrara, R, Maxia, M, Pinna, M, Logias, F, Cogoni, G, Cadinu, F, Ghisu, T, Contu, B, Casu, D, Passaghe, M, Pilloni, A, Ganadu, M, Gazzanelli, L

“…The purpose of the study was to examine the effect of hemodiafiltration with endogenous reinfusion (HFR) compared to hemodialysis (HD) on 28 uremic patients…”
Get full text

Role of proteinuria reduction in the progression of IgA nephropathy by Locatelli, F, Pozzi, C, Del Vecchio, L, Bolasco, P G, Fogazzi, G B, Andrulli, S, Melis, P, Altieri, P, Ponticelli, C

“…Proteinuria has been shown to play a causal role in the progression towards ESRD of IgA nephropathy (IgAN). We demonstrated that steroids are effective in…”
Get more information

Pro convection: are convective therapies like hemodiafiltration and hemofiltration the future of extracorporeal blood purification? by Bolasco, P G

“…In recent years, the age and clinical gravity of hemodialysis patients have been steadily increasing. This unavoidable phenomenon is progressively leading…”
Get more information

The treatment of osteodystrophy in dialyzed uremic patients: results of the first Sardinian audit by Mereu, M C, Bolasco, P G, Pinna, A, Carzedda, L G, Branca, G F, Di Lauro, L, Cogoni, G, Solinas, R, Mureddu, S

“…Hyperphosphatemia in the uremic patient undergoing dialysis causes and makes the secondary hyperpharatyroidism progress. Nowadays it has a very important role…”
Get more information

Mediterranean spotted fever with acute renal failure stimulating a relapse in C-ANCA vasculitis by Cabiddu, G, Altieri, P, Pani, A, Melis, P, Conti, M, Ledda, O, Bolasco, P G

Get more information

On-line predilution hemofiltration versus ultrapure high-flux hemodialysis: a multicenter prospective study in 23 patients. Sardinian Collaborative Study Group of On-Line Hemofiltration by Altieri, P, Sorba, G B, Bolasco, P G, Bostrom, M, Asproni, E, Ferrara, R, Bolasco, F, Cossu, M, Cadinu, F, Cabiddu, G F, Casu, D, Ganadu, M, Passaghe, M, Pinna, M

“…The aims of the present prospective multicenter study were to assess the clinical tolerance and well being, the correlation between nPCr and Kt/V and the…”
Get more information

Hyperparathyroidism resulting from chronic renal insufficiency. Diagnosis and therapy by Nicolosi, A, Malloci, A, Addis, E, Altieri, P, Bolasco, P G, Mereu, M C, Tarquini, A

“…Twenty-seven patients, eighteen females and nine males, with chronic renal failure and secondary hyperparathyroidism, were treated by subtotal…”
Get more information

Pseudoporphyria cutanea tarda: eventual pathogenetic role of the extracorporeal circuits by Aste, N, Altieri, P, Bolasco, P G, Barracca, A, Biggio, P

Get more information

Cutaneous manifestations in uremic patients under periodic hemodialysis therapy by Aste, N, Altieri, P, Mulas, P, Bolasco, P G, Barracca, A

Get more information